Unbranded site aims to elevate awareness of Sjögren's

Share this article:

Daiichi-Sankyo partnered with the Sjögren's Syndrome Foundation on a survey of 400 patients and launched an unbranded site, LivingWithDryness.com, to raise awareness of the condition.

The company makes Evoxac, which is indicated for the treatment of dry mouth due to Sjögren's, an autoimmune disorder that affects an estimated 4 million Americans. The disease causes immune cells to attack and destroy moisture-producing glands, causing dry mouth and dry eyes as well as fatigue, joint pain and digestive problems.

The drug is not mentioned on the disease awareness site, which was built by Digitas Health.

MS&L is handling PR around the release of the survey, which found that Sjögren's patients typically experienced symptoms for three or more years before receiving an accurate diagnosis. That's partly because symptoms are similar to those of lupus and rheumatoid arthritis, and can be mistaken for part of the natural aging process, said Michael Brennan, DDS, MHS, director of the Sjögren's Syndrome and Salivary Disorders Center at Carolinas Medical Center in Charlotte, NC. Dr. Brennan was also quoted in the release saying that loss of saliva due to the disease can cause more serious problems, such as tooth decay and acid reflux.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?